FULGENT THERAPEUTICS

fulgent-therapeutics-logo

Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients.

#SimilarOrganizations #People #Financial #Website #More

FULGENT THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Temple City, California, United States

Country:
United States

Website Url:
http://www.fulgentgenetics.com

Total Employee:
11+

Status:
Active

Contact:
626-350-0537

Email Addresses:
[email protected]

Total Funding:
34.83 M USD

Technology used in webpage:
SPF Global Site Tag Amazon Google Apps For Business Microsoft Azure DNS US Privacy User Signal Mechanism Amazon Route 53 Amazon Oregon Region KnowBe4


Similar Organizations

baudax-bio-logo

Baudax Bio

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

newbridge-pharmaceuticals-logo

NewBridge Pharmaceuticals

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

ocumension-therapeutics-logo

Ocumension Therapeutics

Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.

raptor-pharmaceuticals-logo

Raptor Pharmaceuticals

Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.

rhythm-pharmaceuticals-logo

Rhythm Pharmaceuticals

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

not_available_image

Santi Therapeutics

Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.


Current Advisors List

ming-hsieh_image

Ming Hsieh Chairman of Board of Directors @ Fulgent Therapeutics
Board_member

Current Employees Featured

james-liu_image

James Liu
James Liu Director of System Architecture @ Fulgent Therapeutics
Director of System Architecture
2019-01-01

ming-hsieh_image

Ming Hsieh
Ming Hsieh President & Chief Executive Officer @ Fulgent Therapeutics
President & Chief Executive Officer

not_available_image

Hanlin Gao
Hanlin Gao Lab Director and Chief Scientific Officer @ Fulgent Therapeutics
Lab Director and Chief Scientific Officer
2012-02-01

mary-jane-abalos_image

Mary Jane Abalos
Mary Jane Abalos VP Finance @ Fulgent Therapeutics
VP Finance
2020-07-01

not_available_image

Paul Kim
Paul Kim Chief Financial Officer @ Fulgent Therapeutics
Chief Financial Officer

james-liu_image

James Liu
James Liu Enterprise Systems Architect @ Fulgent Therapeutics
Enterprise Systems Architect
2015-06-01

Founder


ming-hsieh_image

Ming Hsieh

Stock Details


Company's stock symbol is NASDAQ:FLGT

Acquisitions List

Date Company Article Price
2021-08-09 CSI Laboratories CSI Laboratories acquired by Fulgent Therapeutics N/A
2021-05-10 FF Gene Biotech FF Gene Biotech acquired by Fulgent Therapeutics 19 M USD

Investments List

Date Company Article Money raised
2022-02-23 Spatial Genomics Fulgent Therapeutics investment in Series A - Spatial Genomics 56 M USD

Official Site Inspections

http://www.fulgentgenetics.com Semrush global rank: 141.81 K Semrush visits lastest month: 619.02 K

  • Host name: ec2-35-167-4-129.us-west-2.compute.amazonaws.com
  • IP address: 35.167.4.129
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...

More informations about "Fulgent Therapeutics" on Search Engine